JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables):
amplitud de titulares -4.3% ·
flujo de acciones -3.3% ·
nuevas posiciones netas -4.5%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 12.70M | $3.29B | n/a | −2 |
| Q2 2026 | 181 | +1 | 1.42B | $361.32B | +5 | −5 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | n/a | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | n/a |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | n/a | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | n/a |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | n/a | −2 |
| Q2 2024 | 21 | n/a | 161.11M | $23.53B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 133.79M | -0.5% | $22.19B | 0.9% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 59.38M | +3.0% | $9.83B | 0.8% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (pasivo) | 30.81M | +1.5% | $5.11B | 0.7% | ▲ Add | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 22.65M | -7.0% | $3.76B | 0.7% | ▼ Trim | 4 | SEC ↗ ×8 |
| 5 | T. Rowe Price ✦ | 10.11M | -37.9% | $1.68B | 0.2% | ▼ Trim | 4 | SEC ↗ ×2 |
| 6 | Fisher Asset Management ✦ | 8.71M | +6.3% | $1.44B | 0.6% | ▲ Add | 4 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 5.27M | +51.6% | $873.27M | 0.9% | ▲ Add | 4 | SEC ↗ ×7 |
| 8 | Arrowstreet Capital ✦ | 3.30M | +39.5% | $547.50M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 9 | Adage Capital Partners ✦ | 1.28M | +36.8% | $212.01M | 0.4% | ▲ Add | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.25M | -28.2% | $207.97M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 1.17M | +20.8% | $194.69M | 0.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | Marshall Wace ✦ | 912.88K | -77.5% | $151.39M | 0.2% | ▼ Trim | 4 | SEC ↗ ×3 |
| 13 | Citadel Advisors ✦ | 664.02K | -64.4% | $110.12M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 14 | Markel Group ✦ | 610.80K | 0.0% | $101.30M | 0.9% | Held | 4 | SEC ↗ ×2 |
| 15 | Tweedy, Browne ✦ | 438.27K | -59.4% | $72.68M | 6.4% | ▼ Trim | 4 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 297.29K | -44.7% | $49.30M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 202.56K | -78.0% | $33.59M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 98.43K | -50.6% | $16.32M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 86.71K | -6.7% | $14.38M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 20 | Fairfax Financial ✦ | 73.40K | 0.0% | $12.18M | 0.7% | Held | 4 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 23.96K | -62.4% | $3.97M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Dodge & Cox ✦ | 21.10K | 0.0% | $3.50M | 0.0% | Held | 4 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Point72 Asset Management | $44.21M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1 tenedores, 136.10K acciones, $33,268 declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 11.07K acc. · $3.04M
Officer · 22.53K acc. · $6.19M
Officer · 15.00K acc. · $3.95M
Officer, Director · 102.31K acc. · $26.70M
Officer, Director · 20.98K acc. · $5.50M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología